G. J. Ossenkoppele

1.1k citations

51 papers · 832 indexed · h-index 18

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment

Papers in

Hematology 27
- Acute Myeloid Leukemia Research 17
- Chronic Myeloid Leukemia Treatments 9
- Hematopoietic Stem Cell Transplantation 6
Genetics 13
- Chronic Lymphocytic Leukemia Research 9

Co-authors: M. M. A. C. Langenhuijsen Arjan A. van de Loosdrecht C J Meijer P. van Heerde Paul van der Valk R.H.J. Beelen Peter C. Huijgens Mehdi Jiwa
Journals: Leukemia Research (6 papers)British Journal of Cancer (3 papers)Haematologica (3 papers)Journal of Clinical Oncology (3 papers)Cancer (2 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

G. J. Ossenkoppele

49 papers receiving 813 citations

Peers

Countries citing papers authored by G. J. Ossenkoppele

Since Specialization

Citations

This map shows the geographic impact of G. J. Ossenkoppele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. J. Ossenkoppele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. J. Ossenkoppele more than expected).

Fields of papers citing papers by G. J. Ossenkoppele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. J. Ossenkoppele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. J. Ossenkoppele. The network helps show where G. J. Ossenkoppele may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G. J. Ossenkoppele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. J. Ossenkoppele Line = papers co-authored together G. J. Ossenkoppele links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel American Journal of Hematology ·Farhad Ravandi, Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie Freeman, Christopher S. Hourigan, G. J. Ossenkoppele, Gail J. Roboz, Marion Subklewe, Christian Thiede, Mike Lyman, Peter J.M. Valk, Adriano Venditti, Andrew H. Wei, Roland B. Walter, Michael Heuser	2023	10
2	Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia International Journal of Laboratory Hematology ·Monique Terwijn, Angèle Kelder, Alexander N. Snel, Me-Qun Xie, Willemijn J. Scholten, Luise Hutzschenreuter, Arjan A. van de Loosdrecht, Sonja Zweegman, G. J. Ossenkoppele, Gerrit‐Jan Schuurhuis	2012	18
3	Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib Leukemia ·Jeroen J. W. M. Janssen, Wendy Deenik, Ann T. Breed, А. В. Ладнева, Walter Pouwels, Angèle Kelder, Jan J. Cornelissen, G.J. Schuurhuis, G. J. Ossenkoppele	2011	23
4	Towards Cure of CML: Why We Need to Know More About CML Stem Cells? Current Stem Cell Research & Therapy ·Stefano Markidis, G.J. Schuurhuis, Monique Terwijn, G. J. Ossenkoppele	2009	1
5	Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome Haematologica ·Martine E.D. Chamuleau, Theresia M. Westers, 河田雅圭, Isabelle Nizet, Adri Zevenbergen, Corien Eeltink, G. J. Ossenkoppele, Arjan A. van de Loosdrecht	2009	50
6	Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia Haematologica ·Corine J. Hess, N Feller, Fedor Denkers, Angèle Kelder, Azra Haghshenas, Michael C. Heinrich, Amy Harlow, Johannes Berkhof, G. J. Ossenkoppele, Quinten Waisfisz, Gerrit‐Jan Schuurhuis	2008	12
7	CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation British Journal of Cancer ·Anita G.M. Stam, Saskia J. Santegoets, Theresia M. Westers, Claudia C. Sombroek, J. Janssen, Bryan Tillman, Arjan A. van de Loosdrecht, Herbert M. Pinedo, David T. Curiel, G. J. Ossenkoppele, R.J. Scheper, Tanja D. de Gruijl	2003	11
8	Final analysis of a randomized study on the value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML Blood ·G. J. Ossenkoppele, Wilfried J. Graveland, Pieter Sonneveld, Bernard Fianku, Douwe H. Biesma, J. M. H. Clark, M Schaafsma, Petra H.M. Westveer, Georg Peters, Paul Noordhuis, Petra Muus, Dominik Selleslag, Bronno van der Holt, Michel Delforge, Bob Löwenberg, Gregor Verhoef	2002	2
9	In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: A report of the Dutch and German Leukemia Study Groups Medical and Pediatric Oncology ·Раднаева Светлана Жамсоевна, R. Pieters, D. Hoelzer, R Släter, Monique L. den Boer, A. H. Loonen, Jochen Harbott, G. Janka‐Schaub, W.-D. Ludwig, G. J. Ossenkoppele, Elisabeth R. van Wering, A. Veerman	2002	18
10	Malignant lymphoma of mucosa-associated lymphoid tissue in the larynx European Archives of Oto-Rhino-Laryngology ·Remco de Bree, Hans F. Mahieu, G. J. Ossenkoppele, Paul van der Valk	1998	29
11	Radiotoxicity of 67-Gallium on myeloid leukemic blasts Leukemia Research ·Andries R. Jonkhoff, Peter C. Huijgens, 正勝上林, Arthur van Lingen, G. J. Ossenkoppele, Angelika M. Dräger, G. J. J. Teule	1995	12
12	Gallium-67 radiotoxicity in human U937 lymphoma cells British Journal of Cancer ·Andries R. Jonkhoff, Peter C. Huijgens, 正勝上林, Nnatuanya Isaac N, G. J. Ossenkoppele, H. Martens, 史璐萍	1993	19
13	Detection of Epstein–Barr virus nucleic acid sequences and protein in nodal T‐cell lymphomas: relation between latent membrane protein‐1 positivity and clinical course Histopathology ·Peter C. de Bruin, Natasha Jiwa, Paul van der Valk, P. van Heerde, 徴収関係判例研究グループ, G. J. Ossenkoppele, J. M. M. Walboomers, C J Meijer	1993	39
14	Differences of cellular composition and adhesion molecule expression in “leukemic” as compared with “normal” human long-term bone marrow cultures Annals of Hematology ·Nicholas Bartholomew, R.H.J. Beelen, G. J. Ossenkoppele, Yuki Tsutsumi, M. M. A. C. Langenhuijsen	1992	14
15	Combining counterflow centrifugal elutriation and glycoprotein lb‐dependent purification of human megakaryocytes: Efficacy and selectivity European Journal Of Haematology ·E. C. M. van Pampus, Donald E. Crook, Peter C. Huijgens, P. Wijermans, G. J. Ossenkoppele, Fernando Rodrı́guez, Adri Zevenbergen, M. M. A. C. Langenhuijsen	1991	6
16	Sinonasal non-Hodgkin's lymphomas and Wegener's granulomatosis: A clinicopathological study Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·L. Arnold Noorduyn, Luis Ernesto Guanoluisa, P. van der Valk, James Mw, G. B. Snow, Pransiska Pransiska, G. J. Ossenkoppele, C. J. L. M. Meyer	1991	13
17	Quantitative enzyme determination in acute myeloid leukemia Leukemia Research ·G. J. Ossenkoppele, D. Mariano Adolfo Vera, Peter C. Huijgens, J. Nauta, M. M. A. C. Langenhuijsen	1991	2
18	Sequential development of peripheral T-cell lymphoma in the course of chronic myelogenous leukemia Cancer ·Marion C. Blonk, Paul van der Valk, Geoffrey C. Beverstock, G. J. Ossenkoppele	1990	12
19	Low dose cytosine-arabinoside has only minimal differentiation inducing capacity in HL60 cells European Journal of Cancer and Clinical Oncology ·G. J. Ossenkoppele, Pierre W. Wijermans, F. C. de Waal, Mayla Awaliah, Wim Jalink, Peter C. Huijgens, M. M. A. C. Langenhuijsen	1989	4
20	Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma European Journal of Cancer and Clinical Oncology ·Peter C. Huijgens, G. J. Ossenkoppele, J. van der Lelie, ARIANA LACERDA GARCIA, 契子須賀, Chelsea Barr	1988	3

About G. J. Ossenkoppele

G. J. Ossenkoppele is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Immunology and Gastroenterology, having authored 51 papers that have together received 832 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (9 papers), Acute Lymphoblastic Leukemia research (9 papers), Retinoids in leukemia and cellular processes (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Viral-associated cancers and disorders (5 papers). The work is most often cited by research in Hematology (309 citations), Pathology and Forensic Medicine (269 citations), Genetics (135 citations), Oncology (308 citations) and Immunology (218 citations). G. J. Ossenkoppele has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include M. M. A. C. Langenhuijsen, Arjan A. van de Loosdrecht, C J Meijer, P. van Heerde, Paul van der Valk, R.H.J. Beelen, Peter C. Huijgens, Mehdi Jiwa, Marion Subklewe and Anthony S. Stein. Their work appears in journals such as Leukemia Research, British Journal of Cancer, Haematologica, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact